First-Line Lenvatinib (Len) Plus Pembrolizumab (Pembro) And Chemotherapy (Chemo) For Metastatic Esophageal Squamous Cell Carcinoma (Mescc): Safety Run-In Results From The Phase III Leap-014 Study
Lenvatinib;Pembrolizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: First-Line Lenvatinib (Len) Plus Pembrolizumab (Pembro) And Chemotherapy (Chemo) For Metastatic Esophageal Squamous Cell Carcinoma (Mescc): Safety Run-In Results From The Phase III Leap-014 Study ### Output: Lenvatinib;Pembrolizumab